
    
      The purpose of this study is to determine whether the omega-3 fatty acid emulsion (Omegaven),
      when used in lieu of the conventional soy-based fat emulsion (Intralipid), is effective in
      the treatment of parenteral nutrition associated liver disease (PNALD).
    
  